Mauricio Brito Teixeira
Overview
Explore the profile of Mauricio Brito Teixeira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duarte Silveira M, Menezes M, Pinto de Souza S, Galvao E, Berretta A, Caldas J, et al.
Sci Rep
. 2023 Oct;
13(1):18405.
PMID: 37891178
SARS-CoV-2 and its different variants caused a "wave and wave" pandemic pattern. During the first wave we demonstrated that standardized Brazilian green propolis extract (EPP-AF®) reduces length of hospital stay...
2.
Duarte Silveira M, Malta-Santos H, Reboucas-Silva J, Teles F, Galvao E, Pinto de Souza S, et al.
Int J Nephrol
. 2022 Dec;
2022:1035475.
PMID: 36457860
Background: Patients on haemodialysis (HD) present a significant inflammatory status, which has a pronounced negative impact on their outcomes. Propolis is a natural resin with anti-inflammatory and immunomodulatory properties. We...
3.
Duarte Silveira M, Pinto de Souza S, Galvao E, Teixeira M, Gomes M, Damiani L, et al.
Trials
. 2022 Apr;
23(1):255.
PMID: 35379306
Background: The 2019 coronavirus disease (COVID-19) pandemic continues to spread and affects large numbers of people with unprecedented impacts. Experimental evidence has already been obtained for use of the standardized...
4.
Duarte Silveira M, de Jong D, Berretta A, Galvao E, Ribeiro J, Cerqueira-Silva T, et al.
Biomed Pharmacother
. 2021 Jul;
138:111526.
PMID: 34311528
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes challenging immune and inflammatory phenomena. Though various therapeutic possibilities have been tested against coronavirus disease 2019 (COVID-19), the most adequate treatment...
5.
Ramos J, da Hora Passos R, Teixeira M, Gobatto A, Coutinho R, Caldas J, et al.
J Crit Care
. 2018 Jul;
47:178-184.
PMID: 30005305
Objectives: Sepsis identification in older patients is challenging. We evaluated the performance of qSOFA across different age groups of patients with suspected infection outside the intensive care unit (ICU). Methods:...